By Neurocrine Biosciences, Inc.

SAN DIEGO , Aug. 26, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at four investor conferences in September.

Chief Financial Officer Matt Abernethy , Chief Commercial Officer Eric Benevich , and Vice-President of Investor Relations Todd Tushla will present at the Cantor Global Healthcare Conference 2025 at 1:00 p.m. ET on Wednesday, September 3, 2025 .

Chief Executive Officer Kyle Gano and Chief Medical Officer Sanjay Keswani will present at the Morgan Stanley 23 rd Annual Global Healthcare Conference at 10:45 a.m. ET on Tuesday, September 9, 2025 .

Chief Executive Officer Kyle Gano , Chief Medical Officer Sanjay Keswani , and Vice-President of Investor Relations Todd Tushla will present at

See Full Page